Harnessing grid computing to save women's lives

Breast cancer is the most common cancer in women. In the EU and the US, one in eight will develop it at some point in their lives, and it will kill one in 28. But harnessing the power of the grid could help increase the accuracy of diagnoses.

Mammography examinations save thousands of women's lives every year. However the rate of misdiagnosis can be high – in some instances up to 30%. This is due in part to physical differences across patient populations, differences in equipment and procedures, and difficulty in using computers to help detect changes in breast tissue.

Computer-aided detection of this potentially fatal cancer, especially when used together with the traditional method of visually screening mammograms, can not only shorten the time needed for analysis, but can also help increase the accuracy of diagnoses.

Novel approach to comparative diagnoses
The team in the European IST project MammoGrid, which ended in August 2005, aimed to apply the power of the grid to see if they could more accurately detect breast cancer. The prototype software that resulted is already enabling users – hospitals, doctors, clinicians, radiologists and researchers – to harness the massive capacity of grid computing to run advanced algorithms on digital mammograms, stored Europe-wide.

The project team also developed a geographically distributed, grid-based database of standardised images and associated patient data. Already, there are 30,000 images stored from over 3,000 patients, equally balanced between the University Hospital of Cambridge in the UK and Udine in Italy.

The novelty of the MammoGrid approach lies in the application of grid technologies to medical diagnoses, and in providing the data and tools to enable users to compare new mammograms with existing ones in the grid database. Users can access mammograms from a variety of sources, and also computer-aided detection algorithms to detect micro-calcifications (tiny specks of calcium in the breast that could indicate cancer) and monitor breast density (dense tissue is considered a major risk factor).

Sharing resources and patient data
"The system in its current version allows users to securely share both resources and patient data which has been treated to ensure anonymity," explains project coordinator David Manset of Maat GKnowledge in Madrid, Spain. "It also supports effective co-working and provides the means for powerful comparative analyses through the use of a standard format for mammogram images".

This break-through functionality could lead to major advances in prevention and detection of the disease. It also opens the door to novel, broad-based statistical analyses of the incidence of breast cancer and its different forms.

MammoGrid+ building on the achievements
Since the project ended, a new consortium independent of IST funding has been set up to further develop the prototype and take it closer to market needs. Under Mammogrid+, a new set of partners (including organisations such as CIEMAT (Spain's Energy, Environmental and Technological Research Centre), CERN (Switzerland), SES (health service for the Extremadura region of Spain, representing the hospitals of Infanta Christina, Don Benito and Merida), and the university hospitals of Cambridge and Udine) is building on the results already achieved.

The new project team has set up four separate sites, to simulate the needs of four different hospitals and test the latest project developments. The results from these tests have been evaluated by a panel of two IT experts and five clinicians from the hospitals in Spain’s Extremadura region.

Their feedback is being incorporated into a pre-commercial release of the software (Mammogrid+ version 1.0) in June 2007. This version is being deployed within the five hospitals collaborating in the project – these hospitals will also receive the hardware infrastructure to host the Mammogrid+ suite.

Future plans include broadening the existing database Europe-wide. Already a further hospital, the university hospital of Cork in Ireland, has shown interest in joining the Mammogrid+ network.

"The inclusion of the new hospitals will increase the coverage of the database and make our knowledge more relevant and more accurate," Manset concludes. "This will allow larger and more refined epidemiological studies. In the end, these techniques could help save lives."

Contact:
David Manset
Maat GKnowledge
Calle San Bernardo num 115, 5 izq
E-28015 Madrid
Spain
Tel: +34 68 780 2661
Fax: +34 67 347 9175
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

For further information, please visit:
www.mammogrid.com

Most Popular Now

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...